The emergence of Chagas disease in the United States and Canada Louis V. KirchhoffRichard D. Pearson Invited Commentary 11 September 2007 Pages: 347 - 350
Sepsis mediators François PhilippartJean-Marc Cavaillon OriginalPaper 11 September 2007 Pages: 358 - 365
Is the septic response good or bad? Willem Joost WiersingaTom van der Poll OriginalPaper Open access 11 September 2007 Pages: 366 - 373
Organ failure in sepsis Herwig GerlachSusanne Toussaint OriginalPaper 11 September 2007 Pages: 374 - 381
Long-term outcomes from sepsis Sachin YendeDerek C. Angus OriginalPaper 11 September 2007 Pages: 382 - 386
Combating the ascendancy of MRSA: Early efforts in eradication of colonization Ellie J. C. Goldstein Clinical Trials Report 11 September 2007 Pages: 389 - 390
Community-associated methicillin-resistant Staphylococcus aureus: Incidence, clinical presentation, and treatment decisions Fredrick M. AbrahamianEric W. Snyder OriginalPaper 11 September 2007 Pages: 391 - 397
Treatment of community-associated methicillin-resistant Staphylococcus aureus Kyle J. PopovichBala HotaRobert A. Weinstein OriginalPaper 11 September 2007 Pages: 398 - 407
New drugs to treat skin and soft tissue infections Gary E. Stein OriginalPaper 11 September 2007 Pages: 408 - 414
Severe skin and soft tissue infections and associated critical illness Donald C. VinhJohn M. Embil OriginalPaper 11 September 2007 Pages: 415 - 421
Treatment of pediatric HIV infection Elisa Antonielli d’OulxElena ChiappiniPier-Angelo Tovo OriginalPaper 11 September 2007 Pages: 425 - 433